Colorectal cancer screening with the fecal immunochemical test in persons aged 30 to 49 years: focusing on the age for commencing screening
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jung, Yoon Suk | - |
dc.contributor.author | Park, Chan Hyuk | - |
dc.contributor.author | Kim, Nam Hee | - |
dc.contributor.author | Park, Jung Ho | - |
dc.contributor.author | Park, Dong Il | - |
dc.contributor.author | Sohn, Chong Il | - |
dc.date.accessioned | 2021-07-30T05:18:03Z | - |
dc.date.available | 2021-07-30T05:18:03Z | - |
dc.date.created | 2021-05-11 | - |
dc.date.issued | 2017-11 | - |
dc.identifier.issn | 0016-5107 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/4021 | - |
dc.description.abstract | Background and Aims: The fecal immunochemical test (FIT) can be an alternative screening method for colorectal cancer in individuals aged <50 years. However, debate continues concerning the age at which commencing FIT is beneficial. Methods: We reviewed the records of participants who had undergone a colonoscopy and FIT as part of a comprehensive health screening program. To determine the age for commencing screening via FIT, participants aged < 50 years were classified into 4 age subgroups as follows: 30 to 34, 35 to 39, 40 to 44, and 45 to 49 years. Average-risk participants aged 50 to 59 years comprised the control group. Results: We analyzed the data of 19,808 participants aged 30 to 49 years and 2233 average-risk participants aged 50 to 59 years. The advanced colorectal neoplasia (ACRN) prevalence in average-risk participants aged 50 to 59 years was 3.8%. In the subgroups of FIT-positive participants, the proportion of participants with ACRN was 2.9% (95% confidence interval [CI], 1.1%-7.4%), 9.7% (95% CI, 5.8%-15.6%), 7.7% (95% CI, 4.5%-12.8%), and 14.6% (95% CI, 8.7%-23.5%) in groups 30 to 34, 35 to 39, 40 to 44, and 45 to 49 years, respectively. The proportion of FIT-positive participants with ACRN in the groups aged 35 to 39, 40 to 44, and 45 to 49 years was higher than that in average-risk participants aged 50 to 59 years (P = .001, P = .014, and P < .001, respectively), whereas that in FIT-positive participants aged 30 to 34 years was not (P = .566). Conclusion: FIT-positive individuals aged 35 to 49 years had a higher risk of ACRN compared with average-risk individuals aged 50 to 59 years. FIT-positive individuals aged 35 to 49 years may benefit from screening colonoscopy, thus justifying the possibility of commencing FIT from age 35 years. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | MOSBY-ELSEVIER | - |
dc.title | Colorectal cancer screening with the fecal immunochemical test in persons aged 30 to 49 years: focusing on the age for commencing screening | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Park, Chan Hyuk | - |
dc.identifier.doi | 10.1016/j.gie.2017.03.1531 | - |
dc.identifier.scopusid | 2-s2.0-85019077969 | - |
dc.identifier.wosid | 000413305600018 | - |
dc.identifier.bibliographicCitation | GASTROINTESTINAL ENDOSCOPY, v.86, no.5, pp.892 - 899 | - |
dc.relation.isPartOf | GASTROINTESTINAL ENDOSCOPY | - |
dc.citation.title | GASTROINTESTINAL ENDOSCOPY | - |
dc.citation.volume | 86 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 892 | - |
dc.citation.endPage | 899 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
dc.subject.keywordPlus | ADVANCED NEOPLASIA | - |
dc.subject.keywordPlus | COLONOSCOPY | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordPlus | GUIDELINES | - |
dc.subject.keywordPlus | COLON | - |
dc.subject.keywordPlus | ASIA | - |
dc.identifier.url | https://linkinghub.elsevier.com/retrieve/pii/S0016510717317674 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.